Investing

Terns Pharmaceuticals : TERN

TERN

Stock Data

$52.95

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Terns Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for serious medical conditions such as cancer, non-alcoholic steatohepatitis (NASH), and obesity. With a pipeline that includes TERN-701 for chronic myeloid leukemia, TERN-501 for NASH, and TERN-601 for NASH and obesity, the company is dedicated to advancing healthcare through innovation. Founded in 2016 and based in Foster City, California, Terns Pharmaceuticals is at the forefront of creating novel therapies for complex diseases.

All Terns Pharmaceuticals Articles

3 Articles

Lee Jackson | Mar 31, 2026 at 8:14 AM EDT

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Arista Networks, Block, Colgate-Palmolive, Digital Realty, Emerson Electric, MiniMed, Shake Shack, and More

Pre-Market Stock Futures: Futures are trading higher this morning after reports are circulating that President Trump wants to end the…

Lee Jackson | Mar 27, 2026 at 8:04 AM EDT

Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More

Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, and, as we mentioned before,…

Rich Duprey | Jun 11, 2025 at 9:27 AM EDT

3 Penny Stocks Wall Street Sees With 243% Upside

Penny stocks captivate investors with their low prices. The allure of controlling large numbers of shares for relatively very little…